Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The cell cycle inhibitor p27Kip1 possesses functions beyond cyclin-cyclin-dependent kinase (CDK) inhibition.
• Investigating these independent functions is crucial for understanding p27Kip1's role in cancer.

Purpose of the Study:

• To generate and analyze a knock-in mouse model (p27CK-) with mutations preventing p27Kip1 interaction with cyclins and CDKs.
• To elucidate the in vivo significance of p27Kip1's cyclin-CDK-independent functions.

Main Methods:

• Generation of a knock-in mouse model (p27CK-) with specific amino acid substitutions in the cdkn1b gene.
• Comparative analysis of tumor development in p27CK- mice versus p27 null mice.
• Assessment of stem/progenitor cell populations in tumor-bearing organs.

Main Results:

• The p27CK- protein, unlike p27 null, caused hyperplastic lesions and tumors in multiple organs (lung, retina, pituitary, ovary, adrenals, spleen, lymphomas).
• Tumorigenesis in the lung and retina was linked to stem/progenitor cell population expansion.
• p27Kip1 promoted stem cell expansion and acted as a dominant oncogene independently of CDK inhibition.

Conclusions:

• p27Kip1 exhibits a dual role in tumorigenesis: a tumor suppressor via cyclin-CDK regulation and an oncogene through a separate mechanism.
• The p27CK- mouse model offers a more accurate representation of p27 misregulation in human cancers than the p27 null model.
• The findings explain the rarity of cdkn1b gene inactivation in human tumors, suggesting oncogenic functions of p27 are often preserved.